Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
Article in Nature Medicine (April 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Nature Medicine (April 2023)
Article in Experimental Hematology & Oncology (June 2021)
Article in Cancer Chemotherapy and Pharmacology (February 2021)